ArticleOphthalmology2016

Cost Evaluation of Panretinal Photocoagulation versus Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.

James Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.